BMJ Open 13 , e068652 (2023)
Wegovy delivered substantial weight loss in women across all menopause stages, plus heart and migraine protection, shown in new data at the European Congress on Obesity Novo Nordisk Novo Nordisk announced data demonstrating that Wegovy (semaglutide 2.4 mg and 7.2 mg) delivers substantial and consistent weight-loss results for women with obesity across reproductive life stages, from premenopausal years through the menopause transition and beyond
According to the United Nations Office on Drugs and Crime, cannabis is the most commonly cultivated, trafficked, and used illicit drug worldwide, with an estimated 192.2 million users (3.9% of the global population) 1
Alternative Formulations: Patients may opt for injections, oral solutions, or other forms
Sunlight and Fresh Air : Nature's own remedy a gentle stroll outside can do wonders
Statistical Analysis The line charts in the figures represent mean SEM